Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2013

May 2, 2013

5229_dirs_2013-05-02_88980b52-8726-47c8-a724-318130c59818.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8659D

AstraZeneca PLC

02 May 2013

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 1 May 2013, the interest of Mene Pangalos, a person discharging managerial responsibilities, in AstraZeneca PLC Ordinary Shares of $0.25 each changed as detailed below. 

The change in interest relates to the vesting of an award of 8,319 shares made in May 2010 under the AstraZeneca Restricted Share Plan. In accordance with the terms of the award, Mr Pangalos has become beneficially entitled to these shares

Following certain tax deductions, Mr Pangalos has received 4,409 shares into a personal brokerage account.

For tax purposes, the fair market value of the shares at vest was 3342.5 pence per share being the closing price of AstraZeneca ordinary shares on the last trading day preceding the vesting day.

A C N Kemp

Company Secretary

2 May 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUUURROVAVRAR